1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.47%
Both yoy net incomes decline, with AVXL at -190.62%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-1.12%
Negative yoy D&A while AVXL is 103.21%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
11.01%
Some yoy growth while AVXL is negative at -23461.63%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
20.13%
Less SBC growth vs. AVXL's 1558.35%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
171.56%
Less working capital growth vs. AVXL's 533.66%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36.25%
AP growth of 36.25% while AVXL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
60.10%
Lower 'other working capital' growth vs. AVXL's 72048.54%. David Dodd would see fewer unexpected short-term demands on cash.
20.13%
Lower 'other non-cash' growth vs. AVXL's 58087.50%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
23.86%
Operating cash flow growth 1.25-1.5x AVXL's 16.21%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
-1272.99%
Negative yoy CapEx while AVXL is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1272.99%
We reduce yoy invests while AVXL stands at 0.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-196.64%
We cut debt repayment yoy while AVXL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
1193.74%
Issuance growth of 1193.74% while AVXL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.